Use of pembrolizumab provided long-term benefits in patients with metastatic melanoma, 10-year look shows
A new 10-year analysis led by Igor Puzanov, MD, MSci, FACP, Director of Early Phase…
Browsing: BRAF inhibitor (BRAFi)
A new 10-year analysis led by Igor Puzanov, MD, MSci, FACP, Director of Early Phase…